Brain-Computer Interface (BCI) for Neurological Conditions | Paradromics
Overview
Paradromics is a company in the neurotechnology sector based in Austin, Texas. The company develops a Brain-Computer Interface (BCI) platform that records brain activity at the level of individual neurons. Its AI algorithms decode this extensive brain data to facilitate the translation of thoughts into treatments. Paradromics aims to address critical unmet medical needs for individuals suffering from paralysis, movement disorders, chronic pain, addiction, depression, and other mental health conditions. Founded by Matt Angle, Ph.D., the company received early funding from the NIH and DARPA to develop its core neurotechnology. Paradromics' first product, the Connexus® BCI, is designed to restore communication for people with severe motor impairments, including those affected by ALS, stroke, or spinal cord injury. The company has received two FDA Breakthrough Device Designations and conducted a successful first-in-human recording in May 2025, with plans to launch a clinical trial in late 2025 to assess the long-term safety and benefits of the Connexus BCI.
Details
- Category
- Biotechnology Research
- Headquarters
- Austin, Texas
- Type
- Privately Held
- Founded
- 2015
- Followers
- 30,026
- Specialties
- Neural Interfaces, Brain Computer Interface, Assistive Communication Devices, BCI, Neuroscience, Neurotechnology, and medical devices
- Locations
- Austin, Texas, US
Oakland, California, US
Funding
Total rounds: 11
Last round: Series unknown, Mar 12, 2025
Similar companies
- https://brainpatch.ai/catalog/company/precision-neuroscience-corporation/667
- https://brainpatch.ai/catalog/company/synchron-inc/640
- https://brainpatch.ai/catalog/company/blackrock-neurotech/609
- https://brainpatch.ai/catalog/company/neurable/815
- https://brainpatch.ai/catalog/company/motif-neurotech-e399c63a/329
- https://brainpatch.ai/catalog/company/inbrain-neuroelectronics/811
- https://brainpatch.ai/catalog/company/openbci/607